These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 12539001

  • 1. Phosphodiesterase type 4 inhibition of activated polymorphonuclear leukocytes in a simulated extracorporeal circulation model.
    Sato Y, Hiramatsu Y, Homma S, Sato S, Onizuka M, Sakakibara Y.
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):172-7. PubMed ID: 12539001
    [Abstract] [Full Text] [Related]

  • 2. Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation.
    Sato Y, Hiramatsu Y, Homma S, Sato M, Sato S, Endo S, Sohara Y.
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):346-50. PubMed ID: 16077397
    [Abstract] [Full Text] [Related]

  • 3. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation.
    Matsuzaki K, Hiramatsu Y, Homma S, Sato S, Shigeta O, Sakakibara Y.
    Ann Thorac Surg; 2005 Aug; 80(2):611-7. PubMed ID: 16039215
    [Abstract] [Full Text] [Related]

  • 4. Phosphodiesterase type 4 inhibitor reduces the retention of polymorphonuclear leukocytes in the lung.
    Sato Y, Sato S, Yamamoto T, Ishikawa S, Onizuka M, Sakakibara Y.
    Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1376-81. PubMed ID: 12003795
    [Abstract] [Full Text] [Related]

  • 5. Nafamostat preserves neutrophil deformability and reduces microaggregate formation during simulated extracorporeal circulation.
    Hiramatsu Y, Homma S, Sato Y, Sato S, Matsuzaki K, Shigeta O, Sakakibara Y.
    Ann Thorac Surg; 2005 Apr; 79(4):1326-32. PubMed ID: 15797071
    [Abstract] [Full Text] [Related]

  • 6. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model.
    Hamamoto M, Suga M, Nakatani T, Takahashi Y, Sato Y, Inamori S, Yagihara T, Kitamura S.
    Eur J Cardiothorac Surg; 2004 May; 25(5):833-8. PubMed ID: 15082290
    [Abstract] [Full Text] [Related]

  • 7. Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.
    Oger S, Behr-Roussel D, Gorny D, Denys P, Lebret T, Alexandre L, Giuliano F.
    Eur Urol; 2007 Mar; 51(3):772-80; discussion 780-1. PubMed ID: 17097801
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
    Jones NA, Leport M, Holand T, Vos T, Morgan M, Fink M, Pruniaux MP, Berthelier C, O'Connor BJ, Bertrand C, Page CP.
    Pulm Pharmacol Ther; 2007 Mar; 20(1):60-8. PubMed ID: 16427796
    [Abstract] [Full Text] [Related]

  • 11. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats.
    Chi ZL, Hayasaka S, Zhang XY, Hayasaka Y, Cui HS.
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2497-502. PubMed ID: 15277469
    [Abstract] [Full Text] [Related]

  • 12. ONO-6818, a novel, potent neutrophil elastase inhibitor, reduces inflammatory mediators during simulated extracorporeal circulation.
    Yoshimura Y, Hiramatsu Y, Sato Y, Homma S, Enomoto Y, Jikuya T, Sakakibara Y.
    Ann Thorac Surg; 2003 Oct; 76(4):1234-9. PubMed ID: 14530017
    [Abstract] [Full Text] [Related]

  • 13. The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
    Thompson BE, Sachs BD, Kantak KM, Cherry JA.
    Eur J Neurosci; 2004 May; 19(9):2561-8. PubMed ID: 15128409
    [Abstract] [Full Text] [Related]

  • 14. A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function.
    Chambers RJ, Abrams K, Castleberry TA, Cheng JB, Fisher DA, Kamath AV, Marfat A, Nettleton DO, Pillar JD, Salter ED, Sheils AL, Shirley JT, Turner CR, Umland JP, Lam KT.
    Bioorg Med Chem Lett; 2006 Feb; 16(3):718-21. PubMed ID: 16263279
    [Abstract] [Full Text] [Related]

  • 15. Specific type IV phosphodiesterase inhibitor ameliorates cerulein-induced pancreatitis in rats.
    Sato T, Otaka M, Odashima M, Kato S, Jin M, Konishi N, Matsuhashi T, Watanabe S.
    Biochem Biophys Res Commun; 2006 Jul 21; 346(1):339-44. PubMed ID: 16759642
    [Abstract] [Full Text] [Related]

  • 16. Phosphodiesterase 4 inhibition of beta2-integrin adhesion caused by leukotriene B4 and TNF-alpha in human neutrophils.
    Meliton AY, Muñoz NM, Lambertino A, Boetticher E, Learoyd J, Zhu X, Leff AR.
    Eur Respir J; 2006 Nov 21; 28(5):920-8. PubMed ID: 16807266
    [Abstract] [Full Text] [Related]

  • 17. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
    Faisy C, Risse PA, Naline E, Guerot E, Fagon JY, Devillier P, Advenier C.
    Life Sci; 2006 Oct 12; 79(20):1929-35. PubMed ID: 16820175
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of eotaxin-mediated human eosinophil activation and migration by the selective cyclic nucleotide phosphodiesterase type 4 inhibitor rolipram.
    Santamaria LF, Palacios JM, Beleta J.
    Br J Pharmacol; 1997 Jul 12; 121(6):1150-4. PubMed ID: 9249251
    [Abstract] [Full Text] [Related]

  • 19. Rolipram inhibits leukocyte-endothelial cell interactions in vivo through P- and E-selectin downregulation.
    Sanz MJ, Alvarez A, Piqueras L, Cerdá M, Issekutz AC, Lobb RR, Cortijo J, Morcillo EJ.
    Br J Pharmacol; 2002 Apr 12; 135(8):1872-81. PubMed ID: 11959789
    [Abstract] [Full Text] [Related]

  • 20. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
    Itoh T, Tokumura M, Abe K.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):135-42. PubMed ID: 15363987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.